➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKesson
Medtronic
Boehringer Ingelheim
Baxter

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

CLOBAZAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Clobazam patents expire, and when can generic versions of Clobazam launch?

Clobazam is a drug marketed by Amneal, Bionpharma Inc, Hetero Labs Ltd Iii, Hikma, Lannett Co Inc, Lupin Ltd, Mylan, Taro, Teva Pharms Usa, Upsher Smith Labs, Vistapharm, Accord Hlthcare, Alkem Labs Ltd, Amneal Pharms Co, Apotex, Breckenridge, Celltrion, Micro Labs, Piramal Hlthcare Uk, and Zydus Pharms. and is included in twenty-seven NDAs.

The generic ingredient in CLOBAZAM is clobazam. There are ten drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the clobazam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clobazam

A generic version of CLOBAZAM was approved as clobazam by AMNEAL on October 22nd, 2018.

  Start Trial

Drug patent expirations by year for CLOBAZAM
Drug Prices for CLOBAZAM

See drug prices for CLOBAZAM

Recent Clinical Trials for CLOBAZAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Greenwich BiosciencesPhase 1
Northwell HealthPhase 1
Besson MariePhase 2

See all CLOBAZAM clinical trials

Pharmacology for CLOBAZAM

US Patents and Regulatory Information for CLOBAZAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs CLOBAZAM clobazam TABLET;ORAL 209687-001 Oct 22, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc CLOBAZAM clobazam TABLET;ORAL 212092-002 Oct 30, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Hetero Labs Ltd Iii CLOBAZAM clobazam TABLET;ORAL 209795-002 Oct 22, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd CLOBAZAM clobazam TABLET;ORAL 210545-001 Dec 14, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma CLOBAZAM clobazam TABLET;ORAL 208785-001 Oct 22, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal CLOBAZAM clobazam SUSPENSION;ORAL 210039-001 Oct 22, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co CLOBAZAM clobazam TABLET;ORAL 209718-002 Oct 22, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Medtronic
Boehringer Ingelheim
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.